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Objective: A new strategy is required in order to regenerate a meniscus for extensive defects. Synovial
mesenchymal stem cells (MSCs) are an attractive cell source for meniscus regeneration due to their high
proliferation and chondrogenic potential. We examined the effect of repetitive intraarticular injections of
synovial MSCs on meniscus regeneration in a massive meniscal defect of pigs. We followed up the ef-
ﬁcacy using MRI evaluation in addition to macroscopic and histological observations.
Design: Two weeks before the injection of synovial MSCs, the anterior half of the medial menisci was
resected in both knees of pigs. Fifty million allogeneic synovial MSCs were injected into the right knee at
0, 2, and 4 weeks and followed up by sequential MRI. The regenerated meniscus, adjacent articular
cartilage, and subchondral bone were evaluated by MRI at 2, 4, 8, 12 and 16 weeks. They were also
evaluated macroscopically and histologically at 16 weeks (n ¼ 7).
Results: The resected meniscus regenerated signiﬁcantly better in the MSC group than in the control
group based on histological and MRI analyses. Macroscopically, the meniscal defect already appeared to
be ﬁlled with synovial tissue at 2 weeks. Articular cartilage and subchondral bone at the medial femoral
condyle were also signiﬁcantly more preserved in the MSC group based on MRI, macroscopic, and his-
tological analyses.
Conclusions: Intraarticular injections of allogeneic synovial MSCs appeared to promote meniscus
regeneration and provide protection at the medial femoral articular cartilage in a porcine massive
meniscal defect model.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The meniscus is a wedge-shaped ﬁbrocartilaginous structure
and plays important roles in load distribution, shock-absorption,
and knee joint stability. It has a poor healing potential due to its
largely avascular nature, and loss of meniscal function leads to
accelerated osteoarthritis1. For a massive meniscal defect in a
clinical situation, the meniscal allograft is indicated, but it is
comparatively invasive, and selecting the proper size of allograft isI. Sekiya, Center for Stem Cell
l University, 1-5-45 Yushima,
17; Fax: 81-3-5803-0170.
ternational. Published by Elsevier Ldifﬁcult2,3. A novel strategy for meniscus regeneration remains
necessary.
It was already reported more than 70 years ago that meniscus
lesions did not heal unless they communicated with the synovium
and capsule4. However, the reparative potential of synovium for
meniscus lesion is limited and therefore spontaneous repair of the
injured meniscus cannot be expected in many cases. Synovial
mesenchymal stem cells (MSCs) are an attractive cell source for
articular cartilage and meniscus regeneration. In comparison with
other tissue-derived MSCs, synovial MSCs have a high chondro-
genic potential5,6 and remarkable expansion ability with autolo-
gous human serum7.
We previously reported that intraarticular injection of synovial
MSCs promotedmeniscus regeneration after the anterior half of thetd. All rights reserved.
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pothesized that this method would also be useful in bigger animals
that are more closely related to humans. The purpose of this study
was to examine the effect of repetitive intraarticular injections of
allogeneic synovial MSCs on the regeneration of the meniscus in a
massive meniscal defect model of pigs. We followed up on
meniscus regeneration sequentially using MRI, and examined the
results macroscopically and histologically at the endpoint. The
articular cartilage and subchondral bone were also sequentially
evaluated to examine the function of the regenerated meniscus.
This study showed the effect of synovial MSCs on meniscus
regeneration, and it may lead to the development of a new treat-
ment for meniscus regeneration in clinical situations.
Materials and methods
Animals
All experiments were conducted in accordance with the insti-
tutional guidelines for the care and use of experimental animals at
Tokyo Medical and Dental University and Jichi Medical University.
Thirteen-month-old, skeletally mature Mexican hairless pigs (Na-
tional Livestock Breeding Center, Ibaraki, Japan) were used. The
average weight of these pigs was 32 kg. All pigs were bred under
speciﬁc pathogen-free conditions and had free access during the
study period to food and water in a post-operative care cage
(400 cm wide, 1210 cm long and 1090 cm high). To remove donor
variation, only one pig was used as a donor for transplantation of
allogeneic synovial MSCs, and 10 pigs were used as recipients.
Cell isolation and culture
Synovial tissue was taken together with the underlying con-
nective tissue from the suprapatellar pouch, which overlays the
non-cartilaginous areas of the femur through an arthrotomy of the
knee. Synovial tissue with the underlying connective tissue was
digested in 3 mg/mL collagenase D solution (Roche Diagnostics,
Mannheim, Germany) in a-minimal essential medium (a-MEM;
Invitrogen, Carlsbad, CA) at 37C for 3 h, ﬁltered through a 70-mm
nylon ﬁlter (BD Biosciences, Franklin Lakes, NJ). The nucleated cells
were plated in 150-cm2 culture dishes (Nunc, Rochester, NY) at
5105 cells/dish in completemedium (a-MEM supplemented with
10% fetal bovine serum (FBS), 100 U/L penicillin, 100 mg/mL strep-
tomycin and 250 ng/mL amphotericin B [all from Invitrogen]) in
150-cm2 culture dishes (Nunc), then cultured for 14 days at 37C, 5%
CO2 with saturated humidity. The mediumwas changed to remove
non-adherent cells every 4e5 days. The adherent cells were har-
vested with 0.25% trypsin-EDTA (Invitrogen) and cryopreserved as
passage 0. Aliquots of 2106 cells in 2mL of stockmedium [a-MEM
supplemented with 10% FBS and 5% dimethylsulfoxide (Wako,
Osaka, Japan)] were frozen slowly in a Cryo 1C freezing container
(Nunc) and cryopreserved at 80C. To expand the cells, a frozen
vial of the cells was thawed, plated in 60-cm2 culture dishes at
1  106 cells/dish, and cultured for 4 days as passage 1. Then the
cells were re-plated in 150-cm2 culture dishes at 5  105 cells/dish
and cultured for 14 days as passage 2. Passage 2e4 cells were used
for further studies. The number of total cell doublings was 12 at
passage 0,18 at passage 1, 25 at passage 2, 30 at passage 3, and 37 at
passage 4.
Colony-forming unit assay
Five hundred cells were plated in 60-cm2 dishes, cultured in
complete medium for 14 days, and stained with 0.5% crystal violet
in methanol for 5 min to observe cell colonies.In vitro differentiation assay
For chondrogenesis, 2.5  105 cells were collected at the bot-
tom of a 15-ml polypropylene tube (BD Biosciences) by centrifu-
gation at 450  g for 10 min. The pellets were cultured in
chondrogenesis medium consisting of high-glucose Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen) supplemented with 1 mg/mL
bone morphogenetic protein (BMP)-7 (provided from Stryker
Biotech, Hopkinton, MA), 10 ng/mL transforming growth factor
(TGF)-b3 (R&D Systems, Minneapolis, MN), 100 nM dexametha-
sone (SigmaeAldrich, St Louis, MO), 50 mg/mL ascorbate-2-
phosphate, 40 mg/mL proline, 100 mg/mL pyruvate and 1:100
diluted ITS þ Premix (6.25 mg/mL insulin, 6.25 mg/mL transferrin,
6.25 ng/mL selenious acid, 1.25 mg/mL bovine serum albumin and
5.35 mg/mL linoleic acid; BD Biosciences). For microscopy, the
pellets were embedded in parafﬁn and cut into 5 mm sections.
They were stained with safranin-o fast green, and immunostained
with type II collagen10e12.
For adipogenesis, cells were cultured for 21 days in adipogenic
medium consisting of complete medium supplemented with
100 nM dexamethasone, 0.5 mM isobutyl-methylxanthine (Sigmae
Aldrich) and 50 mM indomethacin (Wako). The adipogenic cultures
were ﬁxed in 4% paraformaldehyde, then stained with fresh oil red-
o solution13.
For calciﬁcation, cells were cultured for 21 days in calciﬁcation
medium consisting of complete medium supplemented with 1 nM
dexamethasone, 20 mM b-glycerol phosphate (Wako) and 50 mg/
mL ascorbate-2-phosphate (SigmaeAldrich). The cells were ﬁxed in
4% paraformaldehyde, then stained with 0.5% alizarin red
solution14.
Meniscectomy
Two weeks before the injection of synovial MSCs, a straight
incisionwas made on the medial side of the knee, the anteromedial
side of the joint capsule was cut, and the anterior horn of the MM
was exposed under general anesthesia. Then the meniscus was
dislocated anteriorly with a forceps, cut vertically at the level of the
medial collateral ligament, and the anterior half of MMwas excised
in both knees.
Intraarticular injection of synovial MSCs
5  107 synovial MSCs were suspended in 1 mL of PBS and
injected into the right knee three times at 2-week intervals (the
ﬁrst injection day was determined as day 0). The same volume of
PBS was injected into the left knee as the control. For the injection,
a 23-gauge needle was inserted at the center of the triangle
formed by the medial side of the patellar ligament, the medial
femoral condyle (MFC), and the medial tibial plateau, toward the
intercondylar space of the femur. Immediately after the injection,
the medial side of the injected knee was kept down for 10 min so
that the injected synovial MSCs could be attached around the
defect of the meniscus15. After waking up from anesthesia, the
pigs were allowed to walk freely without ﬁxation, and without the
administration of immunosuppressive drugs to reduce the risk of
infection.
Macroscopic examination and histological analysis
After 16 weeks, seven pigs were sacriﬁced by overdose intra-
venous injection of KCl under adequately deep general anesthesia.
Samples such as MFCs were examined macroscopically for color,
integrity, and smoothness, and evaluated using the International
Cartilage Repair Society (ICRS) macroscopic score16. Specimens of
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formaldehyde for 7 days, then dehydrated with a gradient ethanol
series. In order to section ﬁnely, the specimens were decalciﬁed
with 20% EDTA (pH 7.4) at room temperature for 21 days. The
specimens were embedded in parafﬁn and sectioned into slices
5 mm thick radially for the meniscus and sagittally for the con-
dyles. The sections were stained with safranin-o fast green. To
quantify the regeneration of the meniscus, a modiﬁed Pauli’s
scoring system was used17 (Supplementary Table 1). To quantify
the extent of articular cartilage degeneration, the OARSI Osteoar-
thritis Cartilage Histopathology Assessment scoring system was
used18. These scores were evaluated by two observers in a blinded
manner.Immunohistochemistry
For type II collagen, after sequential pretreatments with pro-
teinase K, hydrogen peroxidase, and gout serum, sections were
covered with rabbit anti-human type II collagen antibody (1:1000
dilution; Abcam, Cambridge, UK) and incubated at 4C overnight.
After extensive washing with PBS, the sections were reacted with
the secondary antibody of biotinylated goat anti-rabbit IgG (1:200
in dilution; Vector Laboratories, Burlingame, CA) for 30min at room
temperature. For type I collagen, sections were coveredwithmouse
anti-human type I collagen antibody (1:800 dilution; Abcam) and
incubated at 4C overnight. After washing, the sections were
reacted with the secondary antibody of biotinylated horse anti-
mouse IgG (1:200 in dilution; Vector Laboratories) for 30 min at
room temperature. Immunostaining was detected with the Vec-
tastain ABC reagent (Vector Laboratories) followed by dia-
minobenzidine staining. The sections were counterstained with
hematoxylin.Magnetic resonance imaging evaluation
MRI analysis was performed before meniscectomy, 3 h, 2 weeks,
4 weeks, 8 weeks, 12 weeks and 16 weeks after the ﬁrst injection of
synovial MSCs. An MRI system at 1.5 T (Magnetom Essenza,
Siemens Healthcare Sector, Erlangen, Germany) was used with a 4-
Channel Special-Purpose Coil (Siemens). The coil was positioned in
the medial side of the knees in a standardized fashion using the
MFCs as a landmark. The regenerated meniscus and articular
cartilage were evaluated a using a fast-spin echo proton density
sequence, T1, and quantitative T2 mapping by sagittal plane.
For quantiﬁcation of MRI analysis for the regenerated meniscus,
the mean T2 value at the center of the regenerated region in the T2
mapping images was calculated with Image J software (version
1.43, National Institutes of Health, Bethesda, MD). For quantiﬁca-
tion of MRI analysis for the MFC, a new scoring system, the Whole-
Organ Magnetic Resonance Imaging Score (WORMS), which we
modiﬁed, was used19 (Supplementary Table 2). The score was
evaluated by two investigators blinded to treatment category. The
inter observer variability was examined with interclass correlation
coefﬁcients (ICC) by IBM SPSS statistics 20. The ICC between the
two measures was 0.995.Fig. 1. Representative images for colony formation and multi differentiation of syno-
vial MSCs. (A) Colony formation stained with crystal violet. (B) Macroscopic and his-
tological images for chondrogenesis. (C) Adipogenesis stained with oil red-o. (D)
Calciﬁcation stained with alizarin red.Statistical methods
The StatView 5.0 program (SAS Institute, Cary, NC) was used
for statistical analyses. Comparisons between the MSC group and
the control group were analyzed using the Wilcoxon singled-
ranks test. A P-value of <0.05 was considered statistically
signiﬁcant.Results
Properties of synovial MSCs
Fourteen days after 500 synovial cells were cultured in three
dishes of 60-cm2, 130, 134, and 137 colonies were observed
[Fig. 1(A)]. The pellet of the colony-forming cells differentiated into
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indicating the existence of proteoglycans, and was positive for type
II collagen [Fig. 1(B)]. The colony-forming cells differentiated into
adipocytes stained with oil red-o [Fig. 1(C)] and calciﬁed stained
with alizarin red [Fig. 1(D)].Synovial MSCs promote meniscus regeneration
For analysis of meniscus regeneration, meniscectomy was per-
formed 2 weeks before transplantation of allogeneic synovial
MSCs; then theywere injected three times at 0 weeks, 2 weeks, and
4 weeks. The regenerated meniscus was harvested 16 weeks after
the ﬁrst injection [Fig. 2(A) and (B)].
Macroscopically, the anterior half of the MM, where the native
meniscus was previously removed, appeared to regenerate both in
the MSC and control groups [Fig. 3(A)]. Histologically, the regen-
eratedmeniscus in theMSC groupwas better stainedwith safranin-
o than that in the control group in all seven pigs [Fig. 3(B)].
Representative sections for type I and II collagen indicated that the
positive area for each of them was larger in the regenerated
meniscus transplanted with synovial MSCs than that in the re-
generated meniscus without synovial MSCs. The positive area for
type II collagen almost corresponded to the red area in the sections
stainedwith safranin-o in regeneratedmenisci in theMSC group, in
the control group, and the normal meniscus. The modiﬁed Pauli’s
histological score17 (Supplementary Table 1) was signiﬁcantly
better in the MSC group than in the control group [Fig. 3(C)].Fig. 2. Experimental set up. (A) Schematic drawing for meniscectomy, injection of MSCs, MR
was incised longitudinally to expose MM. (ii) Anterior half of the MM was removed. (iii) 2 w
joint. Area where the meniscus was originally located is indicated with dotted line.The meniscal defect was already ﬁlled with synovial tissue 2
weeks after injection, and the synovial tissue became smooth at 4
and 6 weeks [Fig. 4(A)], though the sequential macroscopic obser-
vation was performed only in the MSC group (n ¼ 1). Sequential
MRI analysis showed the process of meniscus regeneration in the
MSC group [Fig. 4(B)]. The signal intensity in the resected area
increased rapidly 3 h after meniscectomy, then decreased gradually
over the course of time in both groups. The resected area appeared
less disorganized in the MSC group than in the control group at 8,
12, and 16 weeks. Quantiﬁcation analyses demonstrated that the T2
value in the regenerative meniscus was signiﬁcantly lower than in
the control group from 2 weeks through 16 weeks [Fig. 4(C)].Injected MSCs prevent articular cartilage degeneration
Macroscopically, articular cartilage on the MFC appeared to be
better preserved in theMSC side than in the control side in all seven
pigs [Fig. 5(A)]. The ICRS score for macroscopic observation16 was
signiﬁcantly better in the MSC group than in the control group.
Histologically, cartilage and bone also appeared to be better pre-
served in the MSC group in each pig [Fig. 5(B)]. The OARSI score for
histological observation18 was signiﬁcantly better in the MSC group
than in the control group.
Based on sequential MRI observations of MFCs, the articular
cartilage and subchondral bone lesions worsened in the control
group over time [Fig. 5(C)]. Contrarily, in the MSC group, cartilage
was better preserved at each time point. The MRI scoreI, and histological analyses. (B) Meniscectomy and injection of MSCs. (i) Medial capsule
eeks after the meniscectomy, suspension of synovial MSCs was injected into the knee
Fig. 3. Analyses of the regenerated meniscus. Meniscectomy was performed 2 weeks before, synovial MSCs were injected three times at 0, 2, and 4 weeks, then the regenerated
meniscus was harvested 16 weeks after the ﬁrst injection. (A) Macroscopic observation of the medial menisci harvested from the same pig. Regenerated area is indicated with a blue
line. (B) Radial sectioned histologies for the normal and regenerated meniscus stained with safranin-o and immunostained with type I/II collagen. To remove individual variability,
the regenerated menisci in the MSC and control groups of the same pig are shown in the same row. For type I/II collagen, representative sections were shown. The sections derived
from the same pig were surrounded with a gray line. (C) Quantiﬁcation of histology evaluated by modiﬁed Pauli’s scoring system (Supplementary Table 1) (n ¼ 7, P < 0.05 by
Wilcoxon signed-ranks test).
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than in the control group at 8 weeks and thereafter [Fig. 5(D)].
Discussion
The cells derived-from porcine synovium formed colonies,
differentiated into chondrocytes and adipocytes, and were calciﬁed
when cultured in the appropriate differentiation medium, though
they were not derived from a single cell. As MSCs are deﬁned byadherence to culture dish, colony formation, and trilineage differ-
entiation20, our results showed that colony-forming cells derived
from porcine synovium had characteristics of MSCs.
In our model, the MM was cut vertically at the level of the
medial collateral ligament and the anterior half of MM was resec-
ted. Before we started this study, we had thought that the
remaining part of the meniscus might be pushed out of the load-
bearing area of the knee joint because destabilization of the
medial meniscus (DMM) model, in which the MM ligament was
Fig. 4. Sequential observation for the regeneratedmeniscus. (A)Macroscopic images of the tibial side of the knee joint.Meniscectomywasperformed2weeksbeforehand, then synovialMSCs
were injected only once. The bellower ﬁgureswere indicated by the boxes in the upper ﬁgures. Areawhere themeniscuswas removed is shownwith a blue line. The pictures at 6weekswere
reversed horizontally to facilitate visualization. (B) Sequential sagittalMRI of fast-spin echoprotondensity sequence images at the center of the regeneratedmeniscus. Regeneratedmeniscus is
indicated with a red arrow head. (C) Evaluation of T2 value for the regenerated meniscus (n¼ 5, *P< 0.05 byWilcoxon signed-ranks test). T2 image and evaluated area are also shown.
Fig. 5. Analyses of the MFC. Meniscectomy was performed 2 weeks beforehand, synovial MSCs were injected three times at 0, 2, and 4 weeks, then regenerated meniscus was harvested 16 weeks after the ﬁrst injection. (A) Macroscopic
observation and the ICRS score (n ¼ 7, P < 0.05 by Wilcoxon signed-ranks test). (B) Histological observation and the OARSI score (n ¼ 7, P < 0.05 by Wilcoxon signed-ranks test). For histology, radial sectioned slides at the center of the
MFCs stained with safranin-o are shown. (C) Sequential sagittal MRI fast-spin echo proton density sequence images at the center of the MFC. (D) Quantiﬁcation of MRI analysis for the MFC by modiﬁed WORMS19 (Supplementary
Table 2; n ¼ 5, *P < 0.05 by Wilcoxon signed-ranks test).
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D. Hatsushika et al. / Osteoarthritis and Cartilage 22 (2014) 941e950948dissected, is known as an osteoarthritis model in mice21. However,
the remaining part of the meniscus did not extrude markedly as
shown in Fig. 4(A). In this study, we observed the repair process for
only 18 weeks after the anterior half of MM was resected, and the
remaining part of the meniscus may be pushed out of the load-
bearing area of the knee joint after a longer-term follow-up. We
previously examined similar models in rats8,22e24 and rabbits9. The
remaining part of the meniscus did not extrude markedly within
our observation period in all studies we examined.
In this study, allogeneic synovial MSCs were used in order to
avoid donor variation of synovial MSCs. Autologous synovial MSCs
may survive longer than allogeneic ones. However, donor site
morbidity and delay in growing sufﬁcient cells may become
problematic with autologous synovial MSCs. Comparison of autol-
ogous synovial MSCs with allogeneic synovial MSCs for meniscus
regeneration in a pig model will be a subject of our future
investigation.
We showed that the meniscal defect was ﬁrst ﬁlled with syno-
vial tissue; then the meniscus regeneration progressed. The in-
duction of synovial tissue to the meniscus defect and/or the
formation of synovial tissue in the meniscus defect might be an
important initiation for meniscus regeneration. Exogenous synovial
MSCs had the possibility to promote this process.
Though there were no signiﬁcant differences in the size of the
regenerated meniscus between the two groups at 16 weeks based
on macroscopic observation, the histological features in the MSC
group were better than those in the control group. In MRI analysis,
quantiﬁcation of T2 values in the regenerated meniscus was closer
to the native values in the MSC group than in the control group,
particularly at 16 weeks. These ﬁndings demonstrated that the
resected meniscus regenerated better in the MSC group. Intra-
articular injections of synovial MSCs promoted meniscus
regeneration.
Articular cartilage and subchondral bone were better preserved
in the MSC group. We propose two possible explanations for the
results observed. First, even an immaturemeniscusmay protect the
articular cartilage, because the T2 value of the meniscus in the MSC
groupwas already closer to the normal value than the control group
at 4 weeks. Second, injected MSCs may produce trophic factors to
inhibit progression of articular cartilage degeneration.
To the best of our knowledge, only Murphy et al. and Faqeh et al.
have previously reported the effect of injection of MSCs on retar-
dation of articular cartilage degeneration in massive meniscec-
tomized models of large animals. Murphy et al. used goats and
removed the whole MM and the resected anterior cruciate liga-
ment25. In their study, 10 million bone marrow MSCs were injected
into the knee joint. Faqeh et al. used sheep and also removed the
entire MM and anterior cruciate ligament26. They precultured bone
marrow MSCs in chondrogenic media containing TGFb3 and IGF-1;
then 10 million bone marrow MSCs were injected into the joints.
Both Murphy et al. and Faqeh et al. demonstrated that degeneration
of the articular cartilage was reduced in the MSC group. Although
they demonstrated that the MM was markedly regenerated, only
one sample was shown, and quantiﬁcation analysis for the regen-
erated meniscus was not demonstrated in either paper.
Pigs are useful animals for preclinical study. The immune system
of pigs is similar to that of humans. Furthermore, inbred pigs have a
genetically deﬁned and ﬁxed major histocompatibility complex,
making reproducible studies of immunologic mechanisms
possible27. With respect to proliferation and extracellular matrix
synthesis of chondrocytes, human chondrocytes shared more
similarity with porcine than with ovine or equine chondrocytes28.
Though there are multiple reports on the use of dogs and non-
human primates, their use is limited by ethical concerns, espe-
cially in Japan. While larger animals may more closely approximatethe human clinical situation, they carry greater logistical, ﬁnancial,
and ethical considerations. Therefore, the use of minipigs was most
suitable for this study.
We injected synovial MSCs not once but three times because we
thought a single injection might be insufﬁcient for meniscus
regeneration. One account of a similar strategy is based on the
papers by Murphy et al. and Faqeh et al. as mentioned above. The
greater the number of times synovial MSCs are injected, the better
the resected meniscus will regenerate. However, too many repeti-
tive injections may be associated with some adverse events such as
synovitis, ectopic tissue formation, and tumorigenesis. An analysis
to determine the optimal number of injections is required as a next
step.
To investigate MSC trophic factors, we previously performed a
similar study in a rat model22. Human MSCs were injected into the
rat knee joint after the anterior half of the meniscus was resected,
and the changes in transcription in both human and rat genes were
assayed by species-speciﬁc microarrays and real-time RT-PCRs.
Human MSCs injection increased expression of rat type II collagen,
and inhibited osteoarthritis progression. Human MSCs were acti-
vated to express high levels of a series of genes including BMP2 and
parathyroid hormone-like hormones.
In this study, we analyzed knee joints by MRI in addition to
macroscopic and histological evaluation. According to the regula-
tory science recommended by the FDA, evaluation of quantitative
imaging, such as MRI, was required for identifying new predictors
of efﬁcacy in non-clinical and clinical evaluations29. We followed
up on the efﬁcacy and safety of injected synovial MSCs using
sequential MRI evaluation.
In terms of clinical application, we propose ﬁve limitations in
this study. First, the type of defect is an uncommon type. We
removed only the anterior half of the MM. Most types are bucket
handle tears and, after a partial meniscectomy, part of the inner
meniscus is then removed, leaving the rim intact. Second, we used a
model in which a spontaneous repair took place. Apparently a neo-
meniscus is formed relatively rapidly and this is also the case in
other models of large animals such as goats and sheep. Interspecies
differences have to be considered30. Third, we injected synovial
MSCs 2 weeks after the resection. This suggests that the space for
the resected meniscus was still preserved. In a clinical situation,
patients complaining of symptoms after meniscectomy usually
have no space for the resected meniscus. Therefore, some pro-
cedures are required to regain the space for meniscus regeneration.
Fourth, we did not perform a biomechanical test for the regener-
ated meniscus and we do not know the properties of the regener-
ated meniscus. Fifth, for analyses of sequential macroscopic
observation, the sample number in each experiment was low and
quantiﬁcation with the associated statistics was lacking. In spite of
these limitations, the present study demonstrated a novel treat-
ment for regeneration of a massive meniscal defect. This method
has the possibility to regenerate the meniscus and to restore its
functions with low invasiveness.
Conclusion
Repeated intraarticular injections of synovial MSCs appeared to
promote meniscus regeneration and protected articular cartilage in
a pig massive meniscal defect model.
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